Dear Reader,
Pretty soon, the pandemic will be over.
And most of our lives will go back to normal.
But there is ONE pandemic habit that will not change.
And it’s triggering a flood of money into one niche sector of the stock market.
<The 5 Tech Giants of the 2020s>
Sincerely,
Sam Latter
Editor-in-Chief
Altimetry Research
Daily Financial Update Market Pulse: U.S. benchmarks drifted in a narrow range yesterday, buoyed by AI-adjacent names despite broader growth jitters. Traders mulled fresh biotech
Overview of DTX301 Phase 3 Breakthrough Ultragenyx Pharmaceutical (NASDAQ: RARE), a biotech focused on rare genetic diseases, has announced positive interim Phase 3 results for
Morning Brief Market Pulse: Markets shrugged off jitters, leaving growth names with modest gains while financials and energy took a pause. AI chip rollout chatter
